Biotech's movers for the week of June 1st and a preview of the week ahead
- 1 day ago
- 1 min read
With clinical trial disappointments from ADC Therapeutics, Oculis, Celcuity, and Praxis, and a regulatory blowup from Fulcrum, most of the action in biotech this past week was on the downside.









.png)
